Ultra-sensitive tumor-informed ctDNA assay predicts survival in advanced melanoma patients treated with ICI treatment

被引：0
|
作者：
Pan, H. [1 ]
Keller, L. [2 ]
Heidrich, I. [3 ]
Kott, J. [3 ]
Abbott, C. W. [1 ]
Boyle, S. [1 ]
Pugh, J. [1 ]
Chen, R. O. [1 ]
Geidel, G. [3 ]
Ronald, S. [3 ]
Schneider, S. [3 ]
Gebhardt, C. [3 ]
Pantel, K. [3 ]
机构：
[1] Personalis Inc, Fremont, CA USA
[2] Canc Univ Inst Toulouse Oncopole, Toulouse, France
[3] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.398
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P21-8
引用
收藏
页码：S1373 / S1373
页数：1
相关论文
共 50 条
  • [31] Longitudinal ctDNA monitoring using a high sensitivity tumor-informed assay in patients with metastatic HR+/ HER2-breast cancer receiving endocrine therapy and CDK4/ 6 inhibitors
    Fuentes-Antras, Jesus
    Elliott, Mitchell J.
    Echelard, Philippe
    Dou, Aaron
    Veitch, Zachary
    Bedard, Philippe L.
    Amir, Eitan
    Nadler, Michelle B.
    Meti, Nicholas
    Gregorio, Nancy
    Shah, Elizabeth
    Van de Laar, Emily
    Yu, Celeste
    Gates, Lisa
    Murray, Clodagh
    Smith, Christopher G.
    Chevalier, Amber
    Siu, Lillian L.
    Berman, Hal K.
    Cescon, David W.
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Linking Tumor Growth Dynamics to Survival in Ipilimumab-Treated Patients With Advanced Melanoma Using Mixture Tumor Growth Dynamic Modeling
    Feng, Yan
    Wang, Xiaoning
    Suryawanshi, Satyendra
    Bello, Akintunde
    Roy, Amit
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (11): : 825 - 834
  • [33] Circulating tumor DNA (ctDNA) kinetics to predict survival in patients (pts) with unresectable or metastatic melanoma treated with dabrafenib (D) or D plus trametinib (T).
    Syeda, Mahrukh M.
    Wiggins, Jennifer M.
    Corless, Broderick
    Long, Georgina V.
    Flaherty, Keith
    Schadendorf, Dirk
    Nathan, Paul D.
    Robert, Caroline
    Ribas, Antoni
    Davies, Michael A.
    Grob, Jean Jacques
    Gasal, Eduard
    Squires, Matthew
    Marker, Mahtab
    Brase, Jan C.
    Polsky, David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors
    Mantia, Charlene M. M.
    Werner, Lillian
    Stwalley, Brian
    Ritchings, Corey
    Tarhini, Ahmad A. A.
    Atkins, Michael B. B.
    McDermott, David F. F.
    Regan, Meredith M. M.
    MELANOMA RESEARCH, 2022, 32 (01) : 35 - 44
  • [35] Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma
    Theurich, Sebastian
    Rothschild, Sacha I.
    Hoffmann, Michael
    Fabri, Mario
    Sommer, Andrea
    Garcia-Marquez, Maria
    Thelen, Martin
    Schill, Catherine
    Merki, Ramona
    Schmid, Thomas
    Koeberle, Dieter
    Zippelius, Alfred
    Baues, Christian
    Mauch, Cornelia
    Tigges, Christian
    Kreuter, Alexander
    Borggrefe, Jan
    von Bergwelt-Baildon, Michael
    Schlaak, Max
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (09) : 744 - 754
  • [36] Circulating-tumour DNA (ctDNA) detection using an ultra-sensitive next generation sequencing (NGS)-based assay in patients with resected colorectal cancer (CRC) in the phase III ASCOLT trial
    Day, D.
    Starus, A.
    Sieber, O.
    Prasse, D.
    Lamik, A.
    Fredebohm, J.
    Simes, J.
    Day, F.
    Jeffery, M.
    Zielinski, R.
    Singh, M.
    Chong, G.
    Li, S.
    Mouradov, D.
    Chia, J.
    Ali, R.
    Toh, H.
    Jones, F.
    Segelov, E.
    ANNALS OF ONCOLOGY, 2022, 33 : S282 - S283
  • [37] Circulating-tumour DNA (ctDNA) detection using an ultra-sensitive next generation sequencing (NGS)-based assay in patients with resected colorectal cancer (CRC) in the phase III ASCOLT trial
    Day, Daphne
    Starus, Anna
    Sieber, Oliver
    Prasse, Daniela
    Lamik, Agathe
    Fredebohm, Johannes
    Simes, John
    Day, Fiona
    Jeffery, Mark
    Zielinski, Robert
    Singh, Madhu
    Chong, Geoffrey
    Shan, Li
    Mouradov, Dmitri
    Chia, John W. K.
    Ali, Raghib
    Toh, Han Chong
    Jones, Frederick
    Segelov, Eva
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 120 - 121
  • [38] A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab
    Kobeissi, Iyad
    Eljilany, Islam
    Achkar, Tala
    LaFramboise, William A.
    Santana-Santos, Lucas
    Tarhini, Ahmad A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [39] Tumor-associated antigen TA-90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma
    Kelley, MC
    Jones, RC
    Gupta, RK
    Yee, R
    Stern, S
    Wanek, L
    Morton, DL
    CANCER, 1998, 83 (07) : 1355 - 1361
  • [40] Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery
    Peng, Jianhong
    Lin, Junzhong
    Qiu, Miaozhen
    Zhao, Yujie
    Deng, Yuxiang
    Shao, Jianyong
    Ding, Peirong
    Zhang, Huizhong
    Wan, Desen
    Lu, Zhenhai
    Pan, Zhizhong
    TUMOR BIOLOGY, 2017, 39 (07)
12345